Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castleman's Disease”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07085039
What this trial is testing

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman's Disease (CD)Idiopathic Multicentric Castleman's Disease
University of Pennsylvania 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT00092222
What this trial is testing

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Who this might be right for
Lymphoproliferative DisorderHHV-8Malignancy+1 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT02853968
What this trial is testing

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Who this might be right for
Castleman DiseaseAngiofollicular Lymphoid HyperplasiaGLNH+4 more
University of Pennsylvania 130
Not applicableLooking for participantsNCT03300830
What this trial is testing

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

Who this might be right for
Human Immunodeficiency VirusCastleman's DiseaseKaposi's Sarcoma+1 more
National Cancer Institute (NCI) 280
Early research (Phase 1)Study completedNCT00412321
What this trial is testing

A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaGiant Lymph Node Hyperplasia
Centocor, Inc. 67
Not applicableLooking for participantsNCT04968288
What this trial is testing

Natural History of KSHV-Associated Multicentric Castleman s Disease

Who this might be right for
Multicentric Castleman s Disease
National Cancer Institute (NCI) 195
Not applicableUnknownNCT05995834
What this trial is testing

Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS)

Who this might be right for
Idiopathic Multicentric Castleman's Disease
RECORDATI GROUP 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Not applicableLooking for participantsNCT00006518
What this trial is testing

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Who this might be right for
HIVKaposi's SarcomaLymphomas+2 more
National Cancer Institute (NCI) 1,029
Not applicableTemporarily pausedNCT05028621
What this trial is testing

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Who this might be right for
Castleman's Disease (CD)Langerhans Cell Histiocytosis (LCH)Non-Langerhans-Cell Histiocytosis
Case Comprehensive Cancer Center 135
Not applicableLooking for participantsNCT05200715
What this trial is testing

AutoInflammatory Disease Alliance Registry (AIDA)

Who this might be right for
Hereditary Autoinflammatory DiseasesSchnitzler SyndromeBehcet Syndrome+8 more
University of Siena 3,500
Testing effectiveness (Phase 2)Study completedNCT01024036
What this trial is testing

Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 79
Early research (Phase 1)Study completedNCT01183598
What this trial is testing

Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment

Who this might be right for
Castleman's Disease
Hoffmann-La Roche 3
Early research (Phase 1)UnknownNCT00891280
What this trial is testing

Dose-escalation Study of Oral CX-4945

Who this might be right for
Advanced Solid TumorsBreast CancerInflammatory Breast Cancer+2 more
Cylene Pharmaceuticals 55
Early research (Phase 1)Active Not RecruitingNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 155
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345522
What this trial is testing

Anti-IL-6R mAb Injection in Patients With iMCD

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06643091
What this trial is testing

Nintedanib Treatment in Unicentric Castleman Disease

Who this might be right for
Castleman Disease
Assistance Publique - Hôpitaux de Paris 13
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Load More Results